title: Should patients get EPO subcutaneously?
authors.affiliation: University Hospitals of Cleveland, Ohio, USA.
authors.forename: Jay B
authors.initials: JB
authors.lastname: Wish
mesh_terms: D001294:Attitude to Health; D014487:Centers for Medicare and Medicaid Services, U.S.; D016527:Drug Costs; D004363:Drug Utilization / Q000706:statistics & numerical data; D004921:Erythropoietin / Q000008:administration & dosage* / Q000191:economics; D005060:Europe; D019983:Guideline Adherence / Q000706:statistics & numerical data; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D015999:Multivariate Analysis; D017410:Practice Guidelines as Topic; D019984:Quality Indicators, Health Care; D006435:Renal Dialysis / Q000191:economics / Q000523:psychology; D014481:United States
chemical_list: D004921:Erythropoietin